1. Executive Summary
2. Global Cytomegalovirus Diagnostics Market Introduction
2.1. Global Cytomegalovirus Diagnostics Market – Taxonomy
2.2. Global Cytomegalovirus Diagnostics Market –Definitions
2.2.1. Test Type
2.2.2. End User
3. Global Cytomegalovirus Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cytomegalovirus Diagnostics Market Dynamic Factors - Impact Analysis
4. Global Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cytomegalovirus Diagnostics Market, By Test Type, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1. Serology
5.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Cell Culture
5.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Antigenemia Assay
5.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Polymerase Chain Reaction Amplification
5.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Immunohistochemistry
5.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Nucleic Acid Sequence-based Amplification (NASBA)
5.6.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Hybrid Capture Assay
5.7.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
6. Global Cytomegalovirus Diagnostics Market, By Application, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1. Retinitis
6.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Pneumonia
6.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Gastroenteritis
6.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Encephalitis
6.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others (Mouth Ulcers, Pharyngitis, etc.)
6.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Cytomegalovirus Diagnostics Market, By End User, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1. Hospitals
7.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Diagnostic Centers
7.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Cytomegalovirus Diagnostics Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Region, 2018 – 2024
9. North America Cytomegalovirus Diagnostics Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1. Test Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Serology
9.1.2. Cell culture
9.1.3. Antigenemia assay
9.1.4. Polymerase Chain Reaction Amplification
9.1.5. Immunohistochemistry
9.1.6. Nucleic acid sequence-based amplification (NASBA)
9.1.7. Hybrid capture assay
9.2. Application Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Retinitis
9.2.2. Pneumonia
9.2.3. Gastrointestinal Ulcers
9.2.4. Encephalitis
9.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
9.3. End User Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Hospitals
9.3.2. Diagnostic Centers
9.3.3. Others
9.4. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
9.6. North America Cytomegalovirus Diagnostics Market Dynamics – Trends
10. Europe Cytomegalovirus Diagnostics Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
10.1. Test Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Serology
10.1.2. Cell culture
10.1.3. Antigenemia assay
10.1.4. Polymerase Chain Reaction Amplification
10.1.5. Immunohistochemistry
10.1.6. Nucleic acid sequence-based amplification (NASBA)
10.1.7. Hybrid capture assay
10.2. Application Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Retinitis
10.2.2. Pneumonia
10.2.3. Gastrointestinal Ulcers
10.2.4. Encephalitis
10.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
10.3. End User Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Hospitals
10.3.2. Diagnostic Centers
10.3.3. Others
10.4. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
10.6. Europe Cytomegalovirus Diagnostics Market Dynamics – Trends
11. Asia-Pacific Cytomegalovirus Diagnostics Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
11.1. Test Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Serology
11.1.2. Cell culture
11.1.3. Antigenemia assay
11.1.4. Polymerase Chain Reaction Amplification
11.1.5. Immunohistochemistry
11.1.6. Nucleic acid sequence-based amplification (NASBA)
11.1.7. Hybrid capture assay
11.2. Application Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Retinitis
11.2.2. Pneumonia
11.2.3. Gastrointestinal Ulcers
11.2.4. Encephalitis
11.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
11.3. End User Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Hospitals
11.3.2. Diagnostic Centers
11.3.3. Others
11.4. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
11.6. Asia-Pacific Cytomegalovirus Diagnostics Market Dynamics – Trends
12. Latin America Cytomegalovirus Diagnostics Market Analysis, 2012 - 2012 - 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
12.1. Test Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Serology
12.1.2. Cell culture
12.1.3. Antigenemia assay
12.1.4. Polymerase Chain Reaction Amplification
12.1.5. Immunohistochemistry
12.1.6. Nucleic acid sequence-based amplification (NASBA)
12.1.7. Hybrid capture assay
12.2. Application Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Retinitis
12.2.2. Pneumonia
12.2.3. Gastrointestinal Ulcers
12.2.4. Encephalitis
12.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
12.3. End User Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Hospitals
12.3.2. Diagnostic Centers
12.3.3. Others
12.4. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
12.6. Latin America Cytomegalovirus Diagnostics Market Dynamics – Trends
13. Middle East and Africa Cytomegalovirus Diagnostics Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
13.1. Test Type Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Serology
13.1.2. Cell culture
13.1.3. Antigenemia assay
13.1.4. Polymerase Chain Reaction Amplification
13.1.5. Immunohistochemistry
13.1.6. Nucleic acid sequence-based amplification (NASBA)
13.1.7. Hybrid capture assay
13.2. Application Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Retinitis
13.2.2. Pneumonia
13.2.3. Gastrointestinal Ulcers
13.2.4. Encephalitis
13.2.5. Others (Mouth Ulcers, Pharyngitis, etc.)
13.3. End User Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Hospitals
13.3.2. Diagnostic Centers
13.3.3. Others
13.4. Country Analysis 2013 - 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Cytomegalovirus Diagnostics Market - Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
13.6. MEA Cytomegalovirus Diagnostics Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Cell Medical Ltd. (U.K.)
14.2.2. Merck & Co. Inc. (U.S.)
14.2.3. Chimerix, Inc. (U.S.)
14.2.4. Abbott Laboratories (U.S.)
14.2.5. Affymetrix, Inc. (U.S.)
14.2.6. Becton, Dickinson and Company (U.S.)
14.2.7. Bio-Rad Laboratories, Inc. (U.S.)
14.2.8. F. Hoffmann-La Roche Ltd.( Switzerland)
14.2.9. Johnson and Johnson Services Inc.,(U.S.)
15. Research Methodology
16. Key Assumptions and Acronyms